Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-05

FDA Approved: LAMIVUDINE AND ZIDOVUDINE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a generic combination of lamivudine and zidovudine under an Original Application from Aurobindo Pharma Limited for the treatment of HIV-1 infection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine and Zidovudine (Lamivudine and Zidovudine)

Snippet

ORIG AP for LAMIVUDINE AND ZIDOVUDINE (LAMIVUDINE AND ZIDOVUDINE)